1. 3304 Metabolic activity in metastatic melanoma after long-term treatment with anti-PD-1 antibodies. (September 2015) Authors: Kong, B.; Saunders, C.; Liniker, E.; Ramanujam, S.; Guminski, A.; Scolyer, R.; Kefford, R.; Menzies, A.; Long, G.; Carlino, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3302 Safety and Activity of Combined Radiotherapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) with Metastatic Melanoma. (September 2015) Authors: Liniker, E.; Kong, B.; Menzies, A.M.; Cooper, A.; Ramanujam, S.; Lo, S.; Kefford, R.F.; Fogarty, G.B.; Guminski, A.; Wang, T.W.; Carlino, M.S.; Hong, A.; Long, G.V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma. (1st September 2016) Authors: Liniker, E.; Menzies, A. M.; Kong, B. Y.; Cooper, A.; Ramanujam, S.; Lo, S.; Kefford, R. F.; Fogarty, G. B.; Guminski, A.; Wang, T. W.; Carlino, M. S.; Hong, A.; Long, G. V. Journal: Oncoimmunology Issue: Volume 5:Number 9(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3305 PD1 inhibition-induced changes in melanoma and its associated immune infiltrate. Issue 3 (September 2015) Authors: Vilain, R.E.; Kakavand, H.; Menzies, A.M.; Madore, J.; Wilmott, J.; Dobney, R.; Jakrot, V.; Cooper, A.J.; Kong, B.; Lo, S.; Liniker, E.; Saw, R.P.; Thompson, J.F.; Kefford, R.; Carlino, M.S.; Long, G.V.; Scolyer, R.A. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗